

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.96982991 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59807844 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.59807844 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27805042 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.27805042 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.91550015 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.80915186 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.33698335 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.33698335 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.33698335 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.16250817 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.10144460 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.98835050 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.95769066 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.90984342 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60139788 |
| 17 | urea metabolic process (GO:0019627) | 5.57801975 |
| 18 | urea cycle (GO:0000050) | 5.57801975 |
| 19 | cysteine metabolic process (GO:0006534) | 5.57520413 |
| 20 | drug metabolic process (GO:0017144) | 5.49158215 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.39080960 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.31598882 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.29688187 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.28381101 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.20522332 |
| 26 | protein carboxylation (GO:0018214) | 5.20522332 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.19454374 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.17859820 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.17746702 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.13800218 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.10604549 |
| 32 | lysine metabolic process (GO:0006553) | 5.04648678 |
| 33 | lysine catabolic process (GO:0006554) | 5.04648678 |
| 34 | bile acid metabolic process (GO:0008206) | 5.02751134 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 5.02293195 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.92194152 |
| 37 | regulation of complement activation (GO:0030449) | 4.83146651 |
| 38 | ethanol metabolic process (GO:0006067) | 4.82147424 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.76417376 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.73948078 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.73053327 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.67568580 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.66123417 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.62879243 |
| 45 | regulation of plasminogen activation (GO:0010755) | 4.60048024 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.56769002 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.55991051 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.55991051 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55991051 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.50168200 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.50168200 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.49002873 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.49002873 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.47728275 |
| 55 | glycine metabolic process (GO:0006544) | 4.46377074 |
| 56 | acute-phase response (GO:0006953) | 4.39462691 |
| 57 | glutamate metabolic process (GO:0006536) | 4.38126447 |
| 58 | amine catabolic process (GO:0009310) | 4.37786018 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.37786018 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.37783613 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.37288294 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.37225052 |
| 63 | phospholipid efflux (GO:0033700) | 4.36785130 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.29289353 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.24773308 |
| 66 | negative regulation of hemostasis (GO:1900047) | 4.23905994 |
| 67 | negative regulation of blood coagulation (GO:0030195) | 4.23905994 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.23766886 |
| 69 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.23106052 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.20861276 |
| 71 | oxidative demethylation (GO:0070989) | 4.19901466 |
| 72 | drug catabolic process (GO:0042737) | 4.18761729 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 4.18622281 |
| 74 | cellular glucuronidation (GO:0052695) | 4.17996509 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 4.16385830 |
| 76 | plasma lipoprotein particle organization (GO:0071827) | 4.13341264 |
| 77 | ethanol oxidation (GO:0006069) | 4.10282704 |
| 78 | phenylpropanoid metabolic process (GO:0009698) | 4.09960608 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09306684 |
| 80 | regulation of humoral immune response (GO:0002920) | 4.06480217 |
| 81 | protein-lipid complex assembly (GO:0065005) | 4.06132624 |
| 82 | cholesterol efflux (GO:0033344) | 4.01717154 |
| 83 | alkaloid metabolic process (GO:0009820) | 4.01073489 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.96548272 |
| 85 | arginine metabolic process (GO:0006525) | 3.96288924 |
| 86 | ketone body metabolic process (GO:1902224) | 3.95194542 |
| 87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.93652001 |
| 88 | urate metabolic process (GO:0046415) | 3.92657196 |
| 89 | protein-lipid complex subunit organization (GO:0071825) | 3.91789837 |
| 90 | drug transmembrane transport (GO:0006855) | 3.90505222 |
| 91 | fibrinolysis (GO:0042730) | 3.87742718 |
| 92 | negative regulation of coagulation (GO:0050819) | 3.87723377 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.86726407 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.85304659 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.83725662 |
| 96 | organic acid catabolic process (GO:0016054) | 3.82885422 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.82885422 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.80486302 |
| 99 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.79817522 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.75625040 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.73744893 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.73744893 |
| 103 | intestinal cholesterol absorption (GO:0030299) | 3.72843855 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.72097127 |
| 105 | negative regulation of wound healing (GO:0061045) | 3.71195377 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71155791 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.70766993 |
| 108 | cofactor catabolic process (GO:0051187) | 3.70216857 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69440272 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69440272 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68284317 |
| 112 | exogenous drug catabolic process (GO:0042738) | 3.68249901 |
| 113 | diacylglycerol metabolic process (GO:0046339) | 3.67639786 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.66754556 |
| 115 | complement activation, classical pathway (GO:0006958) | 3.64415212 |
| 116 | hormone catabolic process (GO:0042447) | 3.63786956 |
| 117 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63428838 |
| 118 | positive regulation of hemostasis (GO:1900048) | 3.63406222 |
| 119 | positive regulation of blood coagulation (GO:0030194) | 3.63406222 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.62049364 |
| 121 | sterol homeostasis (GO:0055092) | 3.61912826 |
| 122 | flavonoid metabolic process (GO:0009812) | 3.61625316 |
| 123 | lipoprotein metabolic process (GO:0042157) | 3.60363382 |
| 124 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59738156 |
| 125 | complement activation (GO:0006956) | 3.59337067 |
| 126 | cytolysis (GO:0019835) | 3.58935484 |
| 127 | protein activation cascade (GO:0072376) | 3.57249863 |
| 128 | opsonization (GO:0008228) | 3.52509197 |
| 129 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.50161199 |
| 130 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.50161199 |
| 131 | negative regulation of lipase activity (GO:0060192) | 3.48659097 |
| 132 | proline metabolic process (GO:0006560) | 3.46721598 |
| 133 | intestinal absorption (GO:0050892) | 3.46153705 |
| 134 | negative regulation of protein activation cascade (GO:2000258) | 3.45923741 |
| 135 | positive regulation of coagulation (GO:0050820) | 3.38191349 |
| 136 | S-adenosylmethionine metabolic process (GO:0046500) | 3.38009989 |
| 137 | fructose metabolic process (GO:0006000) | 3.31216365 |
| 138 | regulation of apoptotic cell clearance (GO:2000425) | 3.29041736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42230347 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24208963 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.91657087 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49683957 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.26150966 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00905016 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84866344 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02799758 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00113749 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12260310 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10739416 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06419318 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05751547 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9445425 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63071859 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56216815 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52445259 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51660794 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45180378 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43173886 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39617260 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38165076 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37929108 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36278210 |
| 25 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33875477 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33328734 |
| 27 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.30890088 |
| 28 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27434053 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22801156 |
| 30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21848205 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21444862 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20498001 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19830052 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18506223 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16810214 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13210955 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10972063 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10955462 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10848095 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.09938573 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09584095 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07374174 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06430648 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05834042 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05369135 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04901559 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04895673 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04632696 |
| 49 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02342853 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01313850 |
| 51 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98895220 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98300936 |
| 53 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98088123 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97641953 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97510592 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97444649 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97018861 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96309925 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96015964 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95489426 |
| 61 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.95268062 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91906897 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91547799 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 0.91500171 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90905107 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90122629 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 0.89927331 |
| 68 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89864664 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88594605 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88442638 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87860695 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86750432 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86381255 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86271231 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85515021 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85083351 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84701591 |
| 78 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84244982 |
| 79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83965720 |
| 80 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.83542934 |
| 81 | P300_27268052_Chip-Seq_Bcells_Human | 0.83213323 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82509921 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82508289 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82414367 |
| 85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.82386223 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82113930 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81614699 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81315370 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80802653 |
| 90 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80164361 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79560958 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78110457 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77508361 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77113121 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76587210 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75258848 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71687668 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71079029 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69720692 |
| 100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69638775 |
| 101 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68163054 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66752012 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66495722 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65494580 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64601930 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64585893 |
| 107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64118548 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63814318 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60836627 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59813575 |
| 111 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59506755 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58067488 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56480831 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56480831 |
| 115 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54687715 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.54532682 |
| 117 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54106543 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53479077 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53026777 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50676396 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50351378 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50232588 |
| 123 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49691527 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.49662563 |
| 125 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49307184 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47961882 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46957221 |
| 128 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46837180 |
| 129 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46786186 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46568459 |
| 131 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.46257466 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44615275 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42778954 |
| 134 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42619647 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42589420 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42497822 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42317635 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42050266 |
| 139 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41349325 |
| 140 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41343311 |
| 141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39893206 |
| 142 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38628127 |
| 143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38371335 |
| 144 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37923178 |
| 145 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37528314 |
| 146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.37200692 |
| 147 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.36356495 |
| 148 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36011575 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35920860 |
| 150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35754309 |
| 151 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35743406 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.35683682 |
| 153 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.35462215 |
| 154 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35242539 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35239400 |
| 156 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.34856607 |
| 157 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34670914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.30340588 |
| 2 | MP0005360_urolithiasis | 7.73696604 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.31496454 |
| 4 | MP0005365_abnormal_bile_salt | 6.08463993 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05296121 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14922939 |
| 7 | MP0003252_abnormal_bile_duct | 3.94024183 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49196310 |
| 9 | MP0009840_abnormal_foam_cell | 3.13020194 |
| 10 | MP0005083_abnormal_biliary_tract | 3.01322664 |
| 11 | MP0005332_abnormal_amino_acid | 2.98332472 |
| 12 | MP0003195_calcinosis | 2.94188719 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56552711 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.39093016 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.28763657 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.19675066 |
| 17 | MP0000609_abnormal_liver_physiology | 2.13731937 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.07406546 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84150626 |
| 20 | MP0003868_abnormal_feces_composition | 1.83213749 |
| 21 | MP0001764_abnormal_homeostasis | 1.66739234 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60844565 |
| 23 | MP0005451_abnormal_body_composition | 1.46867047 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.45107718 |
| 25 | MP0009697_abnormal_copulation | 1.43173328 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.38881131 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.34383734 |
| 28 | MP0003186_abnormal_redox_activity | 1.31906970 |
| 29 | MP0003011_delayed_dark_adaptation | 1.31778956 |
| 30 | MP0002132_abnormal_respiratory_system | 1.31425551 |
| 31 | MP0009785_altered_susceptibility_to | 1.29033109 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.20953958 |
| 33 | MP0000598_abnormal_liver_morphology | 1.17621173 |
| 34 | MP0005647_abnormal_sex_gland | 1.11439156 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.11278970 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.09585353 |
| 37 | MP0003303_peritoneal_inflammation | 1.07387318 |
| 38 | MP0009764_decreased_sensitivity_to | 1.05706213 |
| 39 | MP0000604_amyloidosis | 1.04022352 |
| 40 | MP0005025_abnormal_response_to | 1.00950366 |
| 41 | MP0002254_reproductive_system_inflammat | 0.98616568 |
| 42 | MP0009763_increased_sensitivity_to | 0.97338177 |
| 43 | MP0003172_abnormal_lysosome_physiology | 0.90839419 |
| 44 | MP0002419_abnormal_innate_immunity | 0.90781628 |
| 45 | MP0008469_abnormal_protein_level | 0.89441052 |
| 46 | MP0009642_abnormal_blood_homeostasis | 0.88678219 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.88525512 |
| 48 | MP0005670_abnormal_white_adipose | 0.88332551 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 0.88055784 |
| 50 | MP0010368_abnormal_lymphatic_system | 0.84741464 |
| 51 | MP0003879_abnormal_hair_cell | 0.83835743 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.83270097 |
| 53 | MP0008260_abnormal_autophagy | 0.81646181 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 0.81321172 |
| 55 | MP0005408_hypopigmentation | 0.80863129 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 0.77861737 |
| 57 | MP0001756_abnormal_urination | 0.77359272 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.76313883 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.76294346 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 0.75695337 |
| 61 | MP0003866_abnormal_defecation | 0.73030592 |
| 62 | MP0001790_abnormal_immune_system | 0.71998085 |
| 63 | MP0005387_immune_system_phenotype | 0.71998085 |
| 64 | MP0001800_abnormal_humoral_immune | 0.71459936 |
| 65 | MP0002971_abnormal_brown_adipose | 0.71197274 |
| 66 | MP0005535_abnormal_body_temperature | 0.71181192 |
| 67 | MP0001661_extended_life_span | 0.70659759 |
| 68 | MP0001835_abnormal_antigen_presentation | 0.70101278 |
| 69 | MP0005000_abnormal_immune_tolerance | 0.70026735 |
| 70 | MP0000685_abnormal_immune_system | 0.70007812 |
| 71 | MP0005334_abnormal_fat_pad | 0.66926337 |
| 72 | MP0001533_abnormal_skeleton_physiology | 0.66326718 |
| 73 | MP0004130_abnormal_muscle_cell | 0.66217422 |
| 74 | MP0000858_altered_metastatic_potential | 0.65854468 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.64244313 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.63960650 |
| 77 | MP0003329_amyloid_beta_deposits | 0.62585785 |
| 78 | MP0003690_abnormal_glial_cell | 0.62192913 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.61754208 |
| 80 | MP0005266_abnormal_metabolism | 0.60948007 |
| 81 | MP0001663_abnormal_digestive_system | 0.59545454 |
| 82 | MP0002928_abnormal_bile_duct | 0.58791705 |
| 83 | MP0009053_abnormal_anal_canal | 0.58706545 |
| 84 | MP0001915_intracranial_hemorrhage | 0.57787454 |
| 85 | MP0002723_abnormal_immune_serum | 0.57441741 |
| 86 | MP0005671_abnormal_response_to | 0.55207372 |
| 87 | MP0004043_abnormal_pH_regulation | 0.53950737 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.52287667 |
| 89 | MP0005448_abnormal_energy_balance | 0.51340693 |
| 90 | MP0005395_other_phenotype | 0.51095664 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.49794733 |
| 92 | MP0005409_darkened_coat_color | 0.49349167 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.49174248 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.47509567 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.46047974 |
| 96 | MP0001545_abnormal_hematopoietic_system | 0.46047974 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.45980554 |
| 98 | MP0004947_skin_inflammation | 0.44904923 |
| 99 | MP0002452_abnormal_antigen_presenting | 0.44620093 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.44576817 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.44571015 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.44547343 |
| 103 | MP0002822_catalepsy | 0.44333489 |
| 104 | MP0003718_maternal_effect | 0.44321999 |
| 105 | MP0005164_abnormal_response_to | 0.43164614 |
| 106 | MP0008874_decreased_physiological_sensi | 0.43099775 |
| 107 | MP0003724_increased_susceptibility_to | 0.42388634 |
| 108 | MP0003953_abnormal_hormone_level | 0.41845296 |
| 109 | MP0008873_increased_physiological_sensi | 0.41571992 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.39975281 |
| 111 | MP0003436_decreased_susceptibility_to | 0.39867992 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.39479862 |
| 113 | MP0003075_altered_response_to | 0.37896547 |
| 114 | MP0005166_decreased_susceptibility_to | 0.37289780 |
| 115 | MP0002168_other_aberrant_phenotype | 0.37105018 |
| 116 | MP0009672_abnormal_birth_weight | 0.36687272 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.35824556 |
| 118 | MP0008872_abnormal_physiological_respon | 0.35655672 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.34169219 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.33988741 |
| 121 | MP0004381_abnormal_hair_follicle | 0.33624723 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.33206296 |
| 123 | MP0002796_impaired_skin_barrier | 0.33076926 |
| 124 | MP0009115_abnormal_fat_cell | 0.32758576 |
| 125 | MP0006082_CNS_inflammation | 0.30882831 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.30587629 |
| 127 | MP0002970_abnormal_white_adipose | 0.30509541 |
| 128 | MP0001853_heart_inflammation | 0.30203310 |
| 129 | MP0000579_abnormal_nail_morphology | 0.29900867 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.29661956 |
| 131 | MP0002135_abnormal_kidney_morphology | 0.28471139 |
| 132 | MP0000249_abnormal_blood_vessel | 0.27803877 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.26810493 |
| 134 | MP0001243_abnormal_dermal_layer | 0.26004785 |
| 135 | MP0004883_abnormal_blood_vessel | 0.24783229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.29233240 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.15422201 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.11798752 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51276107 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.26436906 |
| 6 | Xanthomatosis (HP:0000991) | 6.21209640 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.15722371 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.33141450 |
| 9 | Complement deficiency (HP:0004431) | 5.20435807 |
| 10 | Hyperammonemia (HP:0001987) | 4.69948439 |
| 11 | Joint hemorrhage (HP:0005261) | 4.65957437 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.60273837 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.48331068 |
| 14 | Ketosis (HP:0001946) | 4.46476337 |
| 15 | Epidermoid cyst (HP:0200040) | 4.38639094 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.32190482 |
| 17 | Hyperglycinuria (HP:0003108) | 4.30983971 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.29464449 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24714998 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20479358 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.12065416 |
| 22 | Fat malabsorption (HP:0002630) | 4.04420118 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.02223867 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.87126239 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80304747 |
| 26 | Abnormality of complement system (HP:0005339) | 3.77486493 |
| 27 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75574216 |
| 28 | * Abnormality of glycine metabolism (HP:0010895) | 3.75574216 |
| 29 | * Hyperglycinemia (HP:0002154) | 3.71186074 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.67817331 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61151865 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54000078 |
| 33 | Nephritis (HP:0000123) | 3.50698484 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.50511644 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36913535 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.30910606 |
| 37 | Ketoacidosis (HP:0001993) | 3.29806789 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.29736345 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.23106327 |
| 40 | Gout (HP:0001997) | 3.10664433 |
| 41 | Purpura (HP:0000979) | 3.10305949 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 3.06213535 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.02521379 |
| 44 | Steatorrhea (HP:0002570) | 3.00643781 |
| 45 | Spontaneous abortion (HP:0005268) | 2.93019751 |
| 46 | Myocardial infarction (HP:0001658) | 2.86997513 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.82973115 |
| 48 | * Abnormality of serum amino acid levels (HP:0003112) | 2.80837985 |
| 49 | * Metabolic acidosis (HP:0001942) | 2.75103819 |
| 50 | Vascular calcification (HP:0004934) | 2.73150054 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72974128 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.72974128 |
| 53 | Lethargy (HP:0001254) | 2.69488754 |
| 54 | Skin nodule (HP:0200036) | 2.67988630 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.66404749 |
| 56 | Spastic diplegia (HP:0001264) | 2.52628563 |
| 57 | Acanthocytosis (HP:0001927) | 2.50565775 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.46708914 |
| 59 | Irritability (HP:0000737) | 2.42709973 |
| 60 | Malnutrition (HP:0004395) | 2.42692386 |
| 61 | Cerebral edema (HP:0002181) | 2.42469588 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.41258426 |
| 63 | Neonatal onset (HP:0003623) | 2.40638024 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.39942282 |
| 65 | Pulmonary embolism (HP:0002204) | 2.39467026 |
| 66 | Mitral stenosis (HP:0001718) | 2.39034895 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.38319385 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.36314173 |
| 69 | Cholecystitis (HP:0001082) | 2.36314173 |
| 70 | Cholelithiasis (HP:0001081) | 2.34350768 |
| 71 | Glomerulonephritis (HP:0000099) | 2.31813562 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26664480 |
| 73 | Enlarged kidneys (HP:0000105) | 2.26450665 |
| 74 | Late onset (HP:0003584) | 2.25286214 |
| 75 | Alkalosis (HP:0001948) | 2.23069692 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.23024053 |
| 77 | Vomiting (HP:0002013) | 2.22182923 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.21217499 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.18992153 |
| 80 | Pancreatitis (HP:0001733) | 2.18591671 |
| 81 | Esophageal varix (HP:0002040) | 2.16635198 |
| 82 | Elevated alkaline phosphatase (HP:0003155) | 2.16406753 |
| 83 | Increased purine levels (HP:0004368) | 2.15050104 |
| 84 | Hyperuricemia (HP:0002149) | 2.15050104 |
| 85 | Brushfield spots (HP:0001088) | 2.14894588 |
| 86 | Epistaxis (HP:0000421) | 2.14546735 |
| 87 | Amyloidosis (HP:0011034) | 2.13798152 |
| 88 | Increased serum ferritin (HP:0003281) | 2.13584629 |
| 89 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.13016963 |
| 90 | Rickets (HP:0002748) | 2.10847887 |
| 91 | Gingival bleeding (HP:0000225) | 2.10582457 |
| 92 | Widely patent fontanelles and sutures (HP:0004492) | 2.09514801 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.09078751 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 2.09078751 |
| 95 | Eczematoid dermatitis (HP:0000976) | 2.07412921 |
| 96 | Menorrhagia (HP:0000132) | 2.07339912 |
| 97 | Thrombophlebitis (HP:0004418) | 2.07134195 |
| 98 | Hypophosphatemia (HP:0002148) | 2.02700689 |
| 99 | Joint swelling (HP:0001386) | 2.01853201 |
| 100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99947886 |
| 101 | Abnormality of the gallbladder (HP:0005264) | 1.97186128 |
| 102 | Hemorrhage of the eye (HP:0011885) | 1.97103936 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96596180 |
| 104 | Hypertriglyceridemia (HP:0002155) | 1.95195640 |
| 105 | Abnormality of vitamin metabolism (HP:0100508) | 1.95173164 |
| 106 | Poikilocytosis (HP:0004447) | 1.94760380 |
| 107 | Glycosuria (HP:0003076) | 1.93173117 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 1.93173117 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.92353823 |
| 110 | Gangrene (HP:0100758) | 1.91023733 |
| 111 | Orchitis (HP:0100796) | 1.90886923 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 1.90502489 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85849826 |
| 114 | Renal cortical cysts (HP:0000803) | 1.85724676 |
| 115 | Osteomalacia (HP:0002749) | 1.84974449 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.84213720 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.83741554 |
| 118 | Hyperphosphaturia (HP:0003109) | 1.82966376 |
| 119 | Myositis (HP:0100614) | 1.82678544 |
| 120 | Cerebral palsy (HP:0100021) | 1.82017131 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.73725027 |
| 122 | Abnormal platelet function (HP:0011869) | 1.73725027 |
| 123 | Abnormal platelet volume (HP:0011876) | 1.73288534 |
| 124 | Gingivitis (HP:0000230) | 1.72005458 |
| 125 | Nephrolithiasis (HP:0000787) | 1.70204226 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.69476506 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.68913793 |
| 128 | Abnormal tarsal ossification (HP:0008369) | 1.68578700 |
| 129 | Retrobulbar optic neuritis (HP:0100654) | 1.66580270 |
| 130 | Optic neuritis (HP:0100653) | 1.66580270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.21577774 |
| 2 | FGFR4 | 4.63878778 |
| 3 | SIK1 | 4.43393511 |
| 4 | ERN1 | 4.38297776 |
| 5 | TAOK3 | 2.90221702 |
| 6 | ERBB4 | 2.86336235 |
| 7 | INSRR | 2.84500889 |
| 8 | PRPF4B | 2.35819932 |
| 9 | MAP2K4 | 2.18391254 |
| 10 | RIPK4 | 2.15677019 |
| 11 | PKN2 | 2.13020873 |
| 12 | MST1R | 2.07095247 |
| 13 | MAPK11 | 1.96991038 |
| 14 | TRIB3 | 1.86283699 |
| 15 | FLT3 | 1.79082302 |
| 16 | BLK | 1.65983990 |
| 17 | PIK3CG | 1.62795593 |
| 18 | TYK2 | 1.61624051 |
| 19 | ACVR1B | 1.60082412 |
| 20 | LATS1 | 1.56883444 |
| 21 | TESK2 | 1.55141836 |
| 22 | PTK6 | 1.48496847 |
| 23 | DAPK2 | 1.39329088 |
| 24 | ABL2 | 1.37757567 |
| 25 | ZAP70 | 1.36992954 |
| 26 | FRK | 1.30862474 |
| 27 | MAP3K7 | 1.30732598 |
| 28 | GRK6 | 1.30295950 |
| 29 | FGFR2 | 1.29732940 |
| 30 | NEK9 | 1.26941751 |
| 31 | PINK1 | 1.25774751 |
| 32 | STK38L | 1.23317752 |
| 33 | JAK2 | 1.21140484 |
| 34 | KDR | 1.20046192 |
| 35 | IRAK4 | 1.16970216 |
| 36 | MAP3K10 | 1.15635580 |
| 37 | PRKG2 | 1.12661167 |
| 38 | PRKAA2 | 1.12153034 |
| 39 | TAOK1 | 1.10578427 |
| 40 | WNK3 | 1.08521212 |
| 41 | CDC42BPA | 1.06890255 |
| 42 | MAP2K3 | 1.00950117 |
| 43 | WNK4 | 0.99439734 |
| 44 | TBK1 | 0.98880705 |
| 45 | ERBB2 | 0.97495468 |
| 46 | MAP3K14 | 0.97236560 |
| 47 | MATK | 0.96828824 |
| 48 | JAK1 | 0.95836461 |
| 49 | JAK3 | 0.95399977 |
| 50 | SMG1 | 0.94692453 |
| 51 | MAPK4 | 0.94092730 |
| 52 | KSR2 | 0.93735354 |
| 53 | EPHB1 | 0.91169873 |
| 54 | TNK2 | 0.91155159 |
| 55 | PRKCZ | 0.90492412 |
| 56 | EPHA2 | 0.86522295 |
| 57 | FGR | 0.85548447 |
| 58 | DYRK1B | 0.84664979 |
| 59 | MAP3K3 | 0.80722229 |
| 60 | SGK3 | 0.80117341 |
| 61 | CDK6 | 0.78446473 |
| 62 | FES | 0.76766238 |
| 63 | MET | 0.76403873 |
| 64 | DDR2 | 0.76166044 |
| 65 | LCK | 0.75628673 |
| 66 | MAPK12 | 0.75097370 |
| 67 | BTK | 0.75001608 |
| 68 | MAP3K11 | 0.74759334 |
| 69 | GSK3A | 0.74486188 |
| 70 | TIE1 | 0.74099435 |
| 71 | PDK3 | 0.73653314 |
| 72 | PDK4 | 0.73653314 |
| 73 | MAPK15 | 0.73528438 |
| 74 | SYK | 0.73355136 |
| 75 | PRKACG | 0.72839297 |
| 76 | PRKAA1 | 0.71514174 |
| 77 | TXK | 0.71435318 |
| 78 | EPHA3 | 0.69161102 |
| 79 | LYN | 0.68477556 |
| 80 | CSK | 0.68215445 |
| 81 | OXSR1 | 0.67480126 |
| 82 | RIPK1 | 0.67057108 |
| 83 | PIK3CA | 0.66340423 |
| 84 | IRAK3 | 0.64759611 |
| 85 | FGFR3 | 0.64255314 |
| 86 | MAP2K6 | 0.63910606 |
| 87 | SGK2 | 0.63632263 |
| 88 | SGK223 | 0.61999068 |
| 89 | SGK494 | 0.61999068 |
| 90 | HCK | 0.61609327 |
| 91 | MAP2K2 | 0.60771878 |
| 92 | PTK2 | 0.59310459 |
| 93 | CAMK2G | 0.58699520 |
| 94 | TGFBR2 | 0.57468271 |
| 95 | NLK | 0.57249324 |
| 96 | PDGFRA | 0.57020923 |
| 97 | MAP3K2 | 0.56898878 |
| 98 | CSF1R | 0.55901995 |
| 99 | PDPK1 | 0.55425843 |
| 100 | CAMK1D | 0.55180386 |
| 101 | SIK3 | 0.55134748 |
| 102 | LMTK2 | 0.54961127 |
| 103 | MAPK7 | 0.52573820 |
| 104 | PRKCQ | 0.51312264 |
| 105 | TESK1 | 0.50650350 |
| 106 | CAMKK2 | 0.49002944 |
| 107 | PRKD2 | 0.48753232 |
| 108 | IKBKE | 0.48697140 |
| 109 | PIM2 | 0.47485531 |
| 110 | CSNK1G1 | 0.45254745 |
| 111 | ICK | 0.45093186 |
| 112 | SIK2 | 0.45059016 |
| 113 | CDK4 | 0.44904826 |
| 114 | IKBKB | 0.43643342 |
| 115 | ITK | 0.42947465 |
| 116 | FER | 0.42656870 |
| 117 | TAOK2 | 0.42444250 |
| 118 | NME2 | 0.42351312 |
| 119 | EPHA4 | 0.41151622 |
| 120 | SRC | 0.40538817 |
| 121 | IGF1R | 0.40112483 |
| 122 | MAP3K5 | 0.39609422 |
| 123 | FYN | 0.38923935 |
| 124 | MTOR | 0.38910483 |
| 125 | BMX | 0.38385479 |
| 126 | PDK1 | 0.37938034 |
| 127 | IRAK1 | 0.37681086 |
| 128 | MAP3K13 | 0.37648076 |
| 129 | PAK4 | 0.35905850 |
| 130 | GRK1 | 0.35072321 |
| 131 | PRKCG | 0.32364680 |
| 132 | RET | 0.32348736 |
| 133 | EGFR | 0.31901420 |
| 134 | MAP2K1 | 0.31813401 |
| 135 | PKN1 | 0.31342505 |
| 136 | IRAK2 | 0.29573707 |
| 137 | CAMK4 | 0.27851221 |
| 138 | STK3 | 0.27589524 |
| 139 | MAP3K6 | 0.26896292 |
| 140 | PDK2 | 0.24165409 |
| 141 | MAP3K1 | 0.23765594 |
| 142 | PRKCA | 0.23620382 |
| 143 | MAP4K1 | 0.23525530 |
| 144 | STK38 | 0.22998380 |
| 145 | PAK3 | 0.20804074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40929164 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52172016 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37770067 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36908949 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01223548 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72740727 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68978849 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.64427446 |
| 9 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57328518 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55545782 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48893602 |
| 12 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45842806 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30349215 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29893213 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.15628030 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05738871 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05356060 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88490564 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88162312 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85835403 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85588556 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85061035 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82499954 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76991301 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76577412 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72311337 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71641392 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66207461 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65819798 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64712438 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63243509 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62056581 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59689034 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54119992 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.52312713 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47772847 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40547902 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38882481 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36049010 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32197875 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30792370 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27865858 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23491554 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21742622 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19948231 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19855060 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17921984 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13415146 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11711977 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09473738 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04737710 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03250291 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01907723 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00755539 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97576180 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96032472 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95045571 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93786646 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.88642447 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86898668 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76528743 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76261070 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70998089 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.68240467 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61832568 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61623460 |
| 67 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59531183 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50800745 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46805789 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36605598 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.30796019 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29753382 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25463839 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25010619 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.24141754 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22735782 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18647001 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16369376 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14900171 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.14455900 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11031964 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.10936839 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.08223869 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07659272 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.05558625 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.03527039 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03096034 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2374261 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | -0.2358697 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | -0.2356414 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2336950 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1982987 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1833284 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1794454 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1680888 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1632555 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1595049 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1540431 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1528168 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1503484 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1457708 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1426127 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1117291 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1058260 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1050385 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1035123 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0920463 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0607985 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | -0.0531916 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0506931 |
| 111 | Lysosome_Homo sapiens_hsa04142 | -0.0409883 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0254460 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0150266 |

